Company’s 36-month beta value is 1.73.Analysts have differing opinions on the stock, with 3 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for CYRX is 47.85M, and currently, short sellers hold a 9.26% ratio of that floaft. The average trading volume of CYRX on May 09, 2024 was 454.15K shares.
CYRX) stock’s latest price update
The stock price of CryoPort Inc (NASDAQ: CYRX) has dropped by -19.51 compared to previous close of 16.40. Despite this, the company has seen a fall of -21.48% in its stock price over the last five trading days. Seeking Alpha reported 2024-05-07 that Cryoport, Inc. (NASDAQ:CYRX ) Q1 2024 Earnings Conference Call May 7, 2024 5:00 PM ET Company Participants Todd Fromer – Investor Relations-KCSA Strategic Communications Jerrell Shelton – Chief Executive Officer Mark Sawicki – Chief Scientific Officer Robert Stefanovich – Chief Financial Officer Thomas Heinzen – Vice President-Corporate Development and Investor Relations Conference Call Participants Matt Stanton – Jefferies Philip Song – Leerink Partners Lucas Baranowski – UBS David Larsen – BTIG Paul Knight – KeyBanc Yuan Zhi – B. Riley David Saxon – Needham Operator Good afternoon and welcome to Cryoport Fourth Quarter and Full Year 2023 Earnings Conference Call.
CYRX’s Market Performance
CYRX’s stock has fallen by -21.48% in the past week, with a monthly drop of -29.90% and a quarterly drop of -15.11%. The volatility ratio for the week is 10.22% while the volatility levels for the last 30 days are 5.97% for CryoPort Inc The simple moving average for the past 20 days is -20.77% for CYRX’s stock, with a -10.37% simple moving average for the past 200 days.
Analysts’ Opinion of CYRX
Many brokerage firms have already submitted their reports for CYRX stocks, with B. Riley Securities repeating the rating for CYRX by listing it as a “Neutral.” The predicted price for CYRX in the upcoming period, according to B. Riley Securities is $19 based on the research report published on May 03, 2024 of the current year 2024.
Jefferies, on the other hand, stated in their research note that they expect to see CYRX reach a price target of $21, previously predicting the price at $17. The rating they have provided for CYRX stocks is “Buy” according to the report published on April 04th, 2024.
Needham gave a rating of “Buy” to CYRX, setting the target price at $18 in the report published on March 13th of the current year.
CYRX Trading at -21.97% from the 50-Day Moving Average
After a stumble in the market that brought CYRX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -45.39% of loss for the given period.
Volatility was left at 5.97%, however, over the last 30 days, the volatility rate increased by 10.22%, as shares sank -27.15% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -21.99% lower at present.
During the last 5 trading sessions, CYRX fell by -21.48%, which changed the moving average for the period of 200-days by -17.86% in comparison to the 20-day moving average, which settled at $16.41. In addition, CryoPort Inc saw -14.78% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CYRX starting from SHELTON JERRELL, who sale 2,631 shares at the price of $17.54 back on Mar 25 ’24. After this action, SHELTON JERRELL now owns 692,182 shares of CryoPort Inc, valued at $46,154 using the latest closing price.
Sawicki Mark W, the Chief Scientific Officer of CryoPort Inc, sale 1,367 shares at $17.54 during a trade that took place back on Mar 25 ’24, which means that Sawicki Mark W is holding 77,444 shares at $23,980 based on the most recent closing price.
Stock Fundamentals for CYRX
Current profitability levels for the company are sitting at:
- -0.34 for the present operating margin
- 0.4 for the gross margin
The net margin for CryoPort Inc stands at -0.51. Equity return is now at value -21.87, with -11.34 for asset returns.
When we switch over and look at the enterprise to sales, we see a ratio of 2.87. The liquidity ratio also appears to be rather interesting for investors as it stands at 10.73.
Conclusion
In a nutshell, CryoPort Inc (CYRX) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
